Announced
Al Hammadi Company for Development and Investment to acquire a 35% stake in Sudair Pharmaceuticals from Gulf Investment for $32m.
Synopsis
Al Hammadi Company for Development and Investment, a hospitals and medical centers operator, agreed to acquire a 35% stake in Sudair Pharmaceuticals, a pharmaceutical company, from Gulf Investment, an investment company, for $32m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.